These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31060247)

  • 1. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
    Greenhill K; Hornsby E; Gorman G
    Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31060247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibility study.
    Ross EL; Petty K; Salinas A; Her C; Carpenter JF
    JPEN J Parenter Enteral Nutr; 2023 Mar; 47(3):372-381. PubMed ID: 36582024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
    Holyk AA; Lindner AH; Lindner SE; Shippert BW
    Am J Health Syst Pharm; 2022 Jan; 79(1):e27-e33. PubMed ID: 34390244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors.
    Youssef SH; Garg A; Song Y; Wylie NE; Garg S
    Drug Des Devel Ther; 2024; 18():899-908. PubMed ID: 38533429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
    Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings.
    De Silva DTN; Strunk T; Petrovski M; Page-Sharp M; Moore BR; Batty KT
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
    Lee TM; Villareal CL; Meyer LM
    Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262
    [No Abstract]   [Full Text] [Related]  

  • 10. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the Neonatal Intensive Care Unit.
    Dice JE
    J Pediatr Pharmacol Ther; 2006 Oct; 11(4):233-6. PubMed ID: 23115539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-site Injection Physical Compatibility of Remdesivir with Select Intravenous Drugs Used in Palliative Care and for Treating Coronavirus Disease 2019.
    Kondo M; Gempei M; Watanabe K; Yoshida M; Tagui N; Fukao S; Sugaya K; Takase H
    J Nippon Med Sch; 2023 Nov; 90(5):381-386. PubMed ID: 37271548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Y-Site Compatibility Studies of Parenteral Nutrition and Other Intravenous Medications in Neonatal and Pediatric Patients: A Review of the Literature Evidence.
    Gostyńska A; Przybylski T; Ogrodowczyk M
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
    Kenneally AM; Agbana P; Gardner B; Bae Y; Mitchell T; Beckman EJ
    Am J Health Syst Pharm; 2023 Jan; 80(3):164-170. PubMed ID: 36282720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
    Koller AK; Krebs S; Dörje F
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units.
    Kanji S; Lam J; Johanson C; Singh A; Goddard R; Fairbairn J; Lloyd T; Monsour D; Kakal J
    Crit Care Med; 2010 Sep; 38(9):1890-8. PubMed ID: 20562698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
    Staven V; Iqbal H; Wang S; Grønlie I; Tho I
    J Pharm Pharmacol; 2017 Apr; 69(4):448-462. PubMed ID: 27714809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
    Mediavilla MM; Molina A; Navarro L; Grau L; Pujol MD; Cardenete J; Cardona D; Riera P
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):298-304. PubMed ID: 29992576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.